News Releases

Date	Title	Document
Date Jul 24, 2023	Title Oncocyte Announces 1-For-20 Reverse Stock Split	Document PDF
Date Jun 27, 2023	Title Oncocyte Begins Manufacturing Transplant Blood Test	Document PDF
Date Jun 01, 2023	Title Oncocyte Corporation to Present at the LD Micro Invitational XIII	Document PDF
Date May 11, 2023	Title Oncocyte Reports First Quarter 2023 Financial Results	Document PDF
Date Apr 27, 2023	Title Oncocyte To Announce First Quarter 2023 Financial Results	Document PDF
Date Apr 18, 2023	Title Oncocyte Presents New Data at AACR	Document PDF
Date Apr 12, 2023	Title Oncocyte Announces Reduction in Force	Document PDF
Date Apr 07, 2023	Title Oncocyte Announces Publication of DetermaIO Results from AtezoTRIBE Study in Metastatic Colorectal Cancer	Document PDF
Date Apr 03, 2023	Title Oncocyte Pricing of $13.86 Million Public Offering of Common Stock	Document PDF
Date Mar 31, 2023	Title Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K	Document PDF